← Back to patent-cliff list
索磷布韦
Tier C — Watch / tradeSofosbuvir
Gilead Inc
Originator
2013
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：NS5B
Brand：Sovaldi、Elbanovir、Resof
Indications (approved)：慢性丙型肝炎、丙型肝炎
Regional status
US
批准上市
2013-12-06
EU
批准上市
2014-01-16
China
批准上市
2017-09-20
Japan
批准上市
2015-03-26
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Sofosbuvir?
Approved indications include: 慢性丙型肝炎, 丙型肝炎.
When does the Sofosbuvir patent expire?
No public expiry year is available for Sofosbuvir yet; this page updates once verified.
How do I get a quote for Sofosbuvir intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25